Cardiovascular risk factors after liver transplantation: analysis of related factors

M J Pérez1, D M García, B J Taybi

  • 1Unidad de Hepatología-Trasplante Hepático, Hospital Universitario Carlos Haya, Málaga, Spain. mjimenezp@commalaga.com

Insights

Cardiovascular risk factors (CVRF) are common after liver transplantation. Hepatitis C virus (HCV) infection, especially severe relapse, significantly increases the risk of new-onset diabetes mellitus (DM).

Area of Science:

  • Hepatology
  • Cardiology
  • Transplantation Medicine

Background:

  • Cardiovascular risk factors (CVRF) are a significant concern in liver transplant recipients.
  • Understanding the interplay between immunosuppression, hepatitis C virus (HCV) infection, and CVRF is crucial for patient management.

Purpose of the Study:

  • To analyze the prevalence of CVRF after liver transplantation.
  • To investigate the relationship between immunosuppressive agents and CVRF development.
  • To determine the impact of HCV infection on CVRF post-transplantation.

Main Methods:

  • Retrospective analysis of 158 liver transplants with at least 1-year follow-up.
  • Data collection on pre- and post-transplant CVRF including diabetes mellitus (DM), hypertension, hypertriglyceridemia, hypercholesterolemia, and hyperuricemia.
  • Assessment of the influence of immunosuppression (tacrolimus vs. cyclosporine) and HCV status on CVRF.

Main Results:

  • Hypertension was associated with cyclosporine use (P < .03).
  • HCV infection significantly increased the incidence of de novo DM (P < .01).
  • Severe HCV relapse showed a 4.4-fold increased risk for de novo DM (P < .03).

Conclusions:

  • CVRF commonly develop within the first 3 months post-liver transplantation.
  • HCV-positive patients require special attention due to their elevated risk of de novo DM.
  • Close monitoring for CVRF is essential in liver transplant recipients, particularly those with HCV.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...